ロード中...
New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam
Ceftolozane-tazobactam (C/T) is a new fifth-generation cephalosporin/beta-lactamase inhibitor combination approved by the Food and Drug Administration and the European Medicines Agency for treatment of complicated intraabdominal infections, complicated urinary tract infections, and hospital-acquired...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8218675/ https://ncbi.nlm.nih.gov/pubmed/33875428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02318-20 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|